Eton Pharmaceuticals (ETON) Interest & Investment Income (2018 - 2025)
Eton Pharmaceuticals' (ETON) quarterly Interest & Investment Income came in at -$592000.0 in Q3 2025, down 7300.0% year-on-year from $8222.2 in Q3 2024, and up 43.3% quarter-over-quarter from -$1.0 million in Q2 2025.
Eton Pharmaceuticals (ETON) Interest & Investment Income (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals has disclosed Interest & Investment Income across 5 years of filings, most recently posting -$592000.0 for Q3 2025.
- Interest & Investment Income for Q3 2025 came in at -$592000.0, down 7300.0% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2.7 million (down 2519.61% YoY), and the FY2018 annual result was $164000.0, up 368.57% from the prior year.
- Interest & Investment Income came in at -$592000.0 for Q3 2025 at Eton Pharmaceuticals, up from -$1.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of -$8000.0 in Q3 2024 to a low of -$1.0 million in Q2 2025.
- The 3-year median for Interest & Investment Income is -$124000.0 (2023), against an average of -$335111.1.
- Across the five-year window, Interest & Investment Income surged 91.27% in 2024 and sank 9245.45% in 2025, its largest moves.
- Eton Pharmaceuticals' Interest & Investment Income stood at -$31000.0 in 2023, then surged by 74.19% to -$8000.0 in 2024, then tumbled by 7300.0% to -$592000.0 in 2025.
- The last three Interest & Investment Income figures came in at -$592000.0 (Q3 2025), -$1.0 million (Q2 2025), and -$1.0 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Eton Pharmaceuticals | 833.07 Mn | 807.13 Mn | 13.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -592,000.00 |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | -1.03 Mn |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -52,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Sep 30, 2023 | -31,000.00 |
| Jun 30, 2023 | -124,000.00 |
| Mar 31, 2023 | -126,000.00 |
| Sep 30, 2019 | 77,000.00 |
| Jun 30, 2019 | 100,000.00 |
| Mar 31, 2019 | 144,000.00 |
| Dec 31, 2018 | 82,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Jun 30, 2018 | 28,000.00 |
| Mar 31, 2018 | 29,000.00 |